Darrin W. Hopper - Concepedia

Author

Darrin W. Hopper

University of Virginia

Also Known As

D. W. HOPPER, Darrin W. Hopper

Publications

724

Citations

H-Index

Concepts

All Affiliations

University of Virginia University at Buffalo, State University of New York Pearl River Community College Pfizer (United States)

About

Darrin W. Hopper is an author at University of Virginia specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	102
2	Engineering	3	3	287
3	Biochemistry	3	3	49
4	Biomolecular Engineering	3	3	311
5	Natural Sciences	2	2	38

Darrin W. Hopper

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Highly Regio-, Diastereo-, and Enantioselective C−H Insertions of Methyl Aryldiazoacetates into Cyclic N-Boc-Protected Amines. Asymmetric Synthesis of Novel <i>C</i><sub>2</sub>-Symmetric Amines and <i>threo</i>-Methylphenidate Huw M. L. Davies, Tore Hansen, Darrin W. Hopper, Journal of the American Chemical Society Methyl AryldiazoacetatesEngineeringAsymmetric SynthesisAltmetric Attention ScoreOrganic Chemistry	1999	178
New Strategic Reactions for Organic Synthesis: Catalytic Asymmetric C−H Activation α to Nitrogen as a Surrogate for the Mannich Reaction Huw M. L. Davies, Chandrasekar Venkataramani, Darrin W. Hopper Journal of the American Chemical Society	2003	137
New Strategic Reactions for Organic Synthesis: Catalytic Asymmetric C—H Activation α to Nitrogen as a Surrogate for the Mannich Reaction. Huw M. L. Davies, Chandrasekar Venkataramani, Tore Hansen, ChemInform Abstract AlgebraEngineeringAbstract AnalysisAbstraction (Computer Science)Organic Chemistry	2003	98
Quantification in Patient Urine Samples of Felbamate and Three Metabolites: Acid Carbamate and Two Mercapturic Acids Charles D. Thompson, Mary T. Barthen, Darrin W. Hopper, Epilepsia	1999	55
Characterization of a Receptor Subtype-Selective Lysophosphatidic Acid Mimetic Shelley B. Hooks, Seamus P. Ragan, Darrin W. Hopper, Molecular Pharmacology	1998	54
Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites Huw M. L. Davies, Darrin W. Hopper, Tore Hansen, Bioorganic & Medicinal Chemistry Letters Serotonin Transport SitesPsychoactive DrugMedicineDrug DiscoveryNeurotransmitter	2004	35
Structure/Activity Relationships in Lysophosphatidic Acid: The 2-Hydroxyl Moiety Kevin R. Lynch, Darrin W. Hopper, Steven J. Carlisle, Molecular Pharmacology	1997	34
Novel pyrazolopyrimidines as highly potent B-Raf inhibitors Martin J. Di Grandi, Dan M. Berger, Darrin W. Hopper, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNovel PyrazolopyrimidinesPharmacological AgentPharmacotherapy	2009	29
Structure−Activity Relationships of Lysophosphatidic Acid: Conformationally Restricted Backbone Mimetics Darrin W. Hopper, Seamus P. Ragan, Shelley B. Hooks, Journal of Medicinal Chemistry	1999	23
Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: A class of potent aggrecanase-1 inhibitors Darrin W. Hopper, Matthew D. Vera, David How, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesBiological Evaluation	2009	22

Page 1